S100P calcium-binding protein expression is associated with high-risk proliferative lesions of the breast

Oncology Reports

Volumn 15, Issue 1, 2006, Pages 3-6

  Schor, Ana Paula Torres ^a   Carvalho, Filomena Marino ^a   Kemp, Cláudio ^a   Silva, Ismael D C G ^b   Russo, Jose ^c  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c FOX CHASE CANCER CENTER   (United States)

Author keywords

Breast proliferative lesions; Calcium binding protein; Estrogen receptor; S100P

Indexed keywords

CALCIUM BINDING PROTEIN; ESTROGEN RECEPTOR; KI 67 ANTIGEN; S100P PROTEIN, HUMAN; TUMOR MARKER; TUMOR PROTEIN;

ADULT; AGED; ARTICLE; BREAST DISEASE; BREAST TUMOR; CELL TRANSFORMATION; COMPARATIVE STUDY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; METABOLISM; MIDDLE AGED; PATHOLOGY; PRECANCER; PROGNOSIS; RISK;

ADULT; AGED; AGED, 80 AND OVER; BREAST DISEASES; BREAST NEOPLASMS; CALCIUM-BINDING PROTEINS; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MIDDLE AGED; NEOPLASM PROTEINS; PRECANCEROUS CONDITIONS; PROGNOSIS; RECEPTORS, ESTROGEN; RISK; TUMOR MARKERS, BIOLOGICAL;

EID: 33644876172     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Mariotti C, Feliciotti F, Baldarelli M, et al: Digital sterotactic biopsies for nonpalpable breast lesion. Surg Endosc 17: 911-917, 2003. (Pubitemid 36676900)
2. Dupont WD and Page D: Risk factors for breast cancer in women with proliferative breast disease. N Eng J Med 312: 146-151, 1985. (Pubitemid 15192861)
3. Page D: Cancer risk assessment in benign breast biopsies. Hum Pathol 17: 871-874, 1986.
4. Rosen PP: Rosen's Breast Pathology. 2nd edition. Lippincott Williams & Wilkins, Philadelphia, PA, pp229-248, 2001.
5. Stoll BA: Premalignant breast lesions: role for biological markers in predicting progression to cancer. Eur J Cancer 35: 693-697, 1999.
6. Allred DC and Moshin SK: Biological Features of Human Premalignant Breast Disease. In: Diseases of the Breast. Harry JR, Lippman ME, Morrow M and Osborne CK (eds). Diseases of the Breast, Lippincott Willians & Wilkins, Philadelphia, PA, 2000.
7. Fuqua SAW, Wiltschke C, Zhang QX, et al: A hypersensitive estrogen receptor α mutation in premalignant breast lesions. Cancer Res 60: 4026-4029, 2000. (Pubitemid 30636577)
8. Shoker BS, Jarvis C, Clarke RB, et al: Estrogen receptorpositive proliferating cells in the normal and precancerous breast. Am J Pathol 155: 1811-1815, 1999.
9. Shaaban AM, Sloane JP, West CR and Foster CS: Breast cancer risk in usual ductal hyperplasia is defined by estrogen receptor-α and Ki-67 expression. Am J Pathol 160: 597-604, 2002. (Pubitemid 34160337)
10. Silva IDCG, Salicione AM, Russo IH, Higgy NA, Gebrim LH and Russo J: Tamoxifen down-regulates CD 36 messenger RNA levels in normal and neoplastic human breast tissue. Cancer Res 57: 378-381, 1997. (Pubitemid 27081649)
11. Russo J, Hu YF, Tahin Q, et al: Carcinogenicity of estrogens in human breast epithelial cells. Acta Pathol Microbiol Immunol Scand 109: 39-52, 2001. (Pubitemid 32243473)
12. Hanstein B, Djahansouzi S, Dall P, Beckmann MW and Bender HG: Insights into the molecular biology of the estrogen receptor defines novel therapeutic targets for breast cancer. Eur J Endocrinol 150: 243-255, 2004. (Pubitemid 38443772)
13. Russo J and Russo IH: Genotoxicity of steroidal estrogens. Trends Endocrinol Metab 15: 211-214, 2004. (Pubitemid 38833991)
14. Shao W and Brown M: Advances in estrogen receptor biology: prospects for improvements in target breast cancer therapy. Breast Cancer Res 6: 39-52, 2004. (Pubitemid 38195559)
15. Speirs V and Kerin MJ: Prognostic significance of oestrogen receptor [beta] in breast cancer. Br J Surg 87: 405-409, 2000. (Pubitemid 30192946)
16. Silva IDCG, Hu YF, Russo IH, Ao X, Salicioni AM, Yang X and Russo J: S100P calcium-binding protein overexpression is associated with immortalization of human breast epithelial cells in vitro and early stages of breast cancer development in vivo.Int J Oncol 16: 231-240, 2000.
17. Emoto Y, Kobayashi R, Akatsuba H and Hidaka H: Purification and characterization of a mew member of the S100 protein family from human placenta. Biochem Biophys Res Commun 182: 1246-1253, 1992.
18. 2+-binding protein S100P. J Mol Biol 325: 785-794, 2003.
19. Koltzscher M and Gerke V: Identification of hydrophobic amino acid residues involved in the formation os S100P homodimers in vivo. Biochemistry 39: 9533-9539, 2000. (Pubitemid 30626344)
20. Engelkamp D, Schäfer BW, Mattei MG, Erne P and Heizmann CW: Six S100 genes are clustered on human chromosome 1q21: identification of two genes coding for the two previously unreported calcium-binding proteins S100D and S100E. Proc Natl Acad Sci 90: 6547-6551, 1993. (Pubitemid 23207250)
21. 2+-binding proteins of the S100 family in malignant human breast cancer cell lines and biopsy samples. Int J Cancer 57: 684-990, 1994.
22. Ilg EC, Schäfer BW and Heizmann CW: Expression patterns of S100 calcium-binding proteins in human tumors. Int J Cancer 68: 325-332, 1996. (Pubitemid 26384135)
23. Rudland PS, Platt-Higgins A, Renshaw C, et al: Prognostic significance of the metastasis-inducing protein S100A4 (p9Ka) in human breast cancer. Cancer Res 60: 1595-1603, 2000. (Pubitemid 30183430)
24. Averboukh L, Liang P, Kantoff PW and Pardee AB: Regulation of S100P expression by androgen. Prostate 29: 350-355, 1996. (Pubitemid 27014349)
25. Amler LC, Agus DB, Leduc C, et al: Dysregulated expression of androgen-responsive and nonresponsive genes in the androgen-independent prostate cancer xenograft model CWR22-R1. Cancer Res 60: 6134-6141, 2000.
26. Sato N and Hitomi J: S100P expression in human esophageal epithelial cells: Human esophageal epithelial cells sequentially produce different S100 proteins in the process of differentiation. Anat Rec 267: 60-69, 2002. (Pubitemid 34465299)
27. Zhi H, Zhang J, Hu G, et al: The deregulation of arachidonic acid metabolism-related genes in human esophageal squamous cell carcinoma. Int J Cancer 106: 327-333, 2003. (Pubitemid 36870392)
28. Shyu RY, Huang SL and Jiang SY: Retinoic acid increases expression of the calcium-binding protein S100P in human gastric cancer cells. J Biol Sci 10: 313-319, 2003.
29. Fitzgibbons PL, Henson DE and Hutter RVP for the Cancer Committee of the College of American Pathologists: Benign breast changes and the risk for subsequent breast cancer, an update of the 1985 Consensus Statement. Arch Pathol Lab Mod 122: 1053-1055, 1998.
30. Arumugam T, Simeone DM, Schmidt AM and Logsdon CD: S100P stimulates cell proliferation and survival via receptor for activates glycation end products (RAGE). J Biol Chem 279: 5059-5065, 2004. (Pubitemid 38220521)
31. Russo J and Russo IH: Biological and Molecular Basis of Breast Cancer. Springer, Verlag, Heidelberg, 2004.
32. Russo J, Hu YF, Silva IDCG and Russo IH: Cancer risk related to mammary gland structure and development. Microsc Res Tech 52: 204-223, 2001. (Pubitemid 32107808)
33. Russo J, Hasan Lareef M, Balogh G, Guo S and Russo IH: Estrogen and its metabolites are carcinogenic agents in human breast epithelial cells. J Steroid Biochem Mol Biol 87: 1-25, 2003. (Pubitemid 37421335)